Get started
Author

Robyn Strong

A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors
2018 · Paul J. Wood, Robyn Strong, et al. · Cancer Chemotherapy and Pharmacology · 40
Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors
2023 · Christine L. White, Kathryn M. Kinross, et al. · Journal of Molecular Diagnostics · 26
PDF
Systems-Level Change to Alleviate Barriers to Cancer Clinical Trial Access for Adolescents and Young Adults in Australia
2021 · Justine A. Ellis, Vajiranee S. Malalasekera, et al. · Journal of Adolescent and Young Adult Oncology · 6
A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
2014 · Paul James Wood, Robyn Strong, et al. · Journal of Clinical Oncology · 6
The Australian and New Zealand Children's Haematology/Oncology Group Biobanking Network
2019 · Jennifer Byrne, ANZCHOG Biobanking Network, et al. · Biopreservation and Biobanking · 4
Variations of Surveillance Practice for Patients with Bone Sarcoma: A Survey of Australian Sarcoma Clinicians
2017 · Jeremy Lewin, Kate Thompson, et al. · Sarcoma · 4
PDF
Atrt-08. a Phase Ii Study of Continuous Low Dose Panobinostat in Paediatric Patients With Malignant Rhabdoid Tumors/atypical Teratoid Rhabdoid Tumors
2020 · Paul Wood, Jayesh Desai, et al. · Neuro-Oncology · 3
PDF
ATRT-17. A phase II study of continuous low dose panobinostat in paediatric patients with malignant rhabdoid tumours and atypical teratoid rhabdoid tumours.
2022 · Paul Wood, Jayesh Desai, et al. · Neuro-Oncology · 2
PDF
ID #672 A phase II study of continuous low dose panobinostat in paediatric patients with atypical teratoid rhabdoid tumours (ATRT).
2026 · Elise Young, Dinisha Govender, et al. · Neuro-Oncology Pediatrics
ID #354 Safety, Tolerability and Recommended Phase 2 Dose (RP2D) of VInblastine in Combination with TOvorafenib in Recurrent/progressive low-grade glioma children and Young adults (VICTORY): Results from Phase A of a Canadian/Australian study
2026 · Nirav Thacker, Jordan Hansford, et al. · Neuro-Oncology Pediatrics
ID #112 PAEDNEOVAX - Multicentre, investigator-initiated phase I/II study to assess safety and efficacy of personalised mRNA vaccine targetting tumour-associated neoantigens in children and young adults with high-risk brain tumours.
2026 · Jordan Hansford, Santosh Valvi, et al. · Neuro-Oncology Pediatrics
Path-01. Molecular Profiling of Paediatric Central Nervous System Tumours in Australasia – an Update on the Aim Brain and Mnp2.0 Projects
2020 · Elizabeth Algar, White Christine, et al. · Neuro-Oncology
PDF
Gene-04. Establishing a Molecular Profiling Service for Children’s Central Nervous System Tumors in Australasia – the Australian and New Zealand Children’s Haematology and Oncology Group (anzchog) Aim Brain Project
2019 · Christine White, Kathryn Kinross, et al. · Neuro-Oncology
PDF
Increasing access to clinical trials for adolescents and young adults (AYA) with cancer
2019 · Justine A. Ellis, Anne Woollett, et al. · Asia-Pacific Journal of Clinical Oncology
Works count: 14
Citation count: 91
H-index: 4
I10-index: 2
Year
Topic
Type